Stifel Nicolaus Sticks to Its Buy Rating for Biogen (BIIB)
at www.tipranks.com (Tue, 16-Dec 3:15 AM)
Biogen’s New Study on BIIB145: A Potential Game-Changer for MS Treatment?
at www.tipranks.com (Mon, 15-Dec 11:30 AM)
Nasdaq-100 Reshuffle: Who’s In, Who’s Out?
at www.tipranks.com (Mon, 15-Dec 12:06 AM)
Who Made It to the Nasdaq-100 (NDX) Annual Reshuffle – and Who Did Not?
at www.tipranks.com (Mon, 15-Dec 12:06 AM)
Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Sun, 14-Dec 12:00 PM)
Market Chameleon (Mon, 24-Nov 7:49 AM)
Health Canada Authorizes LEQEMBI: A Pivotal Step for Biogen in Alzheimer’s Treatment Innovation
Market Chameleon (Mon, 27-Oct 8:29 AM)
